Dupilumab Disease Interactions

Arthralgia has been reported with the use of dupilumab. Patients should be advised to report new onset or worsening joint symptoms to their health care provider.

It is unknown if dupilumab with affect the immune response against helminth infections. Patients with preexisting helminth infections should be treated prior to therapy with dupilumab. If patients become infected while receiving dupilumab and do not respond to anthelminthic treatment, dupilumab should be discontinued until the infection resolves.

Conjunctivitis and keratitis adverse reactions have been reported with dupilumab. Care should be exercised when using this agent in patients with visual defects. Patients or their caregivers should be advised to report new onset or worsening eye symptoms to their health care provider.